FDA Approved: BETAMETHASONE DIPROPIONATE — Original Application (Viona Pharmaceuticals Inc)

View source ↗

Summary

FDA approved the original application for Betamethasone Dipropionate by Viona Pharmaceuticals Inc, granting it as a generic topical corticosteroid product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Contact Dermatitis
• Atopic Dermatitis
• Psoriasis

Drugs mentioned

• BETAMETHASONE DIPROPIONATE (Betamethasone dipropionate)

Snippet

ORIG AP for BETAMETHASONE DIPROPIONATE (BETAMETHASONE DIPROPIONATE)